ATE144513T1 - Pyrrolopyrimidinderivate, ihre herstellung und verwendung - Google Patents

Pyrrolopyrimidinderivate, ihre herstellung und verwendung

Info

Publication number
ATE144513T1
ATE144513T1 AT89302851T AT89302851T ATE144513T1 AT E144513 T1 ATE144513 T1 AT E144513T1 AT 89302851 T AT89302851 T AT 89302851T AT 89302851 T AT89302851 T AT 89302851T AT E144513 T1 ATE144513 T1 AT E144513T1
Authority
AT
Austria
Prior art keywords
group
coor
pyrrolopyrimide
derivatives
preparation
Prior art date
Application number
AT89302851T
Other languages
English (en)
Inventor
Hiroshi Akimoto
Takenori Hitaka
Tetsuo Miwa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26412276&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE144513(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE144513T1 publication Critical patent/ATE144513T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT89302851T 1988-03-24 1989-03-22 Pyrrolopyrimidinderivate, ihre herstellung und verwendung ATE144513T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7114988 1988-03-24
JP24537988 1988-09-29

Publications (1)

Publication Number Publication Date
ATE144513T1 true ATE144513T1 (de) 1996-11-15

Family

ID=26412276

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89302851T ATE144513T1 (de) 1988-03-24 1989-03-22 Pyrrolopyrimidinderivate, ihre herstellung und verwendung

Country Status (12)

Country Link
US (4) US4997838A (de)
EP (1) EP0334636B1 (de)
KR (1) KR960015967B1 (de)
CN (1) CN1029970C (de)
AT (1) ATE144513T1 (de)
CA (1) CA1340794C (de)
DE (1) DE68927354T2 (de)
DK (1) DK173980B1 (de)
ES (1) ES2092994T3 (de)
GR (1) GR3021733T3 (de)
HU (3) HU215928B (de)
NO (1) NO169490C (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO169490C (no) * 1988-03-24 1992-07-01 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater
DK0460116T3 (da) * 1989-02-27 1998-03-30 Biocryst Pharm Inc 9-substitueret-8-usubstitueret-9-deazaguaniner
JP3015957B2 (ja) * 1989-05-29 2000-03-06 武田薬品工業株式会社 ピロロ［２，３―ｄ］ピリミジン誘導体およびその製造法
JP2983254B2 (ja) * 1989-06-14 1999-11-29 武田薬品工業株式会社 ピロロ〔２，３―ｄ〕ピリミジン誘導体の製造法およびその中間体
JPH03173890A (ja) * 1989-09-21 1991-07-29 Takeda Chem Ind Ltd ピロロ［２，３―ｄ］ピリミジン誘導体，その製造法，用途及び中間体
CA2031769A1 (en) * 1989-12-08 1991-06-09 Hiroshi Akimoto Pyrrolopyrimidine derivatives, their production and use
US5028608A (en) * 1989-12-11 1991-07-02 The Trustees Of Princeton University N-(6-Amino-(pyrrolo(2,3-d)pyrimidin-3-ylacyl) )-glutamic acid derivatives
IL96531A (en) * 1989-12-11 1995-08-31 Univ Princeton History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them)
KR0162654B1 (ko) * 1989-12-11 1998-11-16 알렌 제이. 시니스갤리 N-(피롤로[2,3-d]피리미딘-3-일아크릴)-글루타민산 유도체
US5248775A (en) * 1989-12-11 1993-09-28 The Trustees Of Princeton University Pyrrolo(2,3-d)pyrimidines
CA2032695A1 (en) * 1989-12-20 1991-06-21 Hiroshi Akimoto Condensed heterocyclic compounds, their production and use
EP0438261A3 (en) * 1990-01-16 1992-02-26 Takeda Chemical Industries, Ltd. Condensed heterocyclic glutamic acid derivatives, their production and use
CA2057635A1 (en) * 1990-12-14 1992-06-15 Hiroshi Akimoto Condensed heterocyclic compounds, their production and use
US5217974A (en) * 1991-03-29 1993-06-08 Eli Lilly And Company Method for treating gar-transformylase tumors in mammals and reducing mammalian toxicity
DE69216509T2 (de) * 1991-08-12 1997-05-28 Takeda Chemical Industries Ltd Kondensierte Pyrimidinderivate, ihre Herstellung und ihre Verwendung als Antitumormittel
ATE173251T1 (de) * 1991-08-21 1998-11-15 Eisai Co Ltd Kondensierte pyrimidinderivate als antitumorverbindungen
US5254687A (en) 1991-12-04 1993-10-19 The Trustees Of Princeton University Process for the preparation of pyrrolo[2,3-d]pyrimidines
US5196424A (en) * 1992-03-24 1993-03-23 Eli Lilly And Company N-[2-amino-4-substituted[[(pyrrollo or pyrido)[2,3-d]pyrimidinyl]-alkyl]benzoyl]-L-glutamic acids
US5235053A (en) 1992-06-22 1993-08-10 Eli Lilly And Company Process for the synthesis of 4-hydroxy-5-halopyrrold[2,3-d]pyrimidine intermediates
US5278307A (en) * 1992-09-25 1994-01-11 Eli Lilly And Company Process for preparing 4-hydroxypyrrolo(2,3-d)pyrimidine based antifolate compounds and intermediates
CZ283281B6 (cs) * 1992-09-25 1998-02-18 Eli Lilly And Company Způsob přípravy v poloze 5 substituovaných pyrrolo(2,3-d)pyrimidinů
US5416211A (en) * 1992-09-25 1995-05-16 Eli Lilly And Company Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines
US5426187A (en) * 1993-11-30 1995-06-20 Eli Lilly And Company Process for the preparation of 4-hydroxy-5-substituted ethynylpyrrolo [2,3-d]pyrimidine intermediates
US6395733B1 (en) 1995-06-07 2002-05-28 Pfizer Inc Heterocyclic ring-fused pyrimidine derivatives
ES2203642T3 (es) * 1995-06-07 2004-04-16 Pfizer Inc. Derivados de pirimidina heterociclicos con anillos condensados.
AU1794697A (en) * 1996-03-06 1997-09-22 Novartis Ag 7-alkyl-pyrrolo{2,3-d}pyrimidines
JP2000516961A (ja) * 1996-08-30 2000-12-19 イーライ・リリー・アンド・カンパニー 非古典的ピロロ［２，３―ｄ］ピリミジン抗葉酸物質
HUP0003954A3 (en) * 1997-09-26 2002-12-28 Lilly Co Eli Processes and intermediates useful to prepare pyrrolo [2,3-d] pyrimidine derivatives
US6162914A (en) * 1998-04-24 2000-12-19 Cerbios-Pharma S.A. Process for the reduction of pterins
PA8474101A1 (es) 1998-06-19 2000-09-29 Pfizer Prod Inc Compuestos de pirrolo [2,3-d] pirimidina
US6066732A (en) * 1998-08-21 2000-05-23 The Trustees Of Princeton University Process for the preparation of pyrrolo[2,3-d]pyrimidines
PL352159A1 (en) * 1999-05-24 2003-07-28 Sankyo Co Pharmaceutical compositions containing antibody against the fas
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6229413B1 (en) 1999-10-19 2001-05-08 General Electric Company Support of stationary conductors for a circuit breaker
SK287188B6 (sk) 1999-12-10 2010-02-08 Pfizer Products Inc. Pyrolo [2,3-d]pyrimidínová zlúčenina, jej použitie a farmaceutická kompozícia alebo kombinácia s jej obsahom
JP4846158B2 (ja) * 2000-02-25 2011-12-28 イーライ リリー アンド カンパニー Ｎ−［４−［２−（２−アミノ−４，７−ジヒドロ−４−オキソ−３Ｈ−ピロロ［２，３−ｄ］ピリミジン−５−イル）エチル］ベンゾイル］−Ｌ−グルタミン酸の新規結晶形およびその製造方法
US6380829B1 (en) 2000-11-21 2002-04-30 General Electric Company Motor operator interlock and method for circuit breakers
WO2003002661A1 (en) * 2001-06-28 2003-01-09 Toray Industries, Inc. Epoxy resin composition excellent in weather resistance and fiber-reinforced composite materials
CN1717236A (zh) 2002-11-26 2006-01-04 辉瑞产品公司 治疗移植排斥的方法
CN100379729C (zh) * 2006-04-06 2008-04-09 海南天源康泽医药科技有限公司 硝基化合物及其在培美曲塞制备中的应用
WO2008089390A1 (en) * 2007-01-19 2008-07-24 Chelsea Therapeutics, Inc. New classical antifolates
EP2129674A2 (de) * 2007-04-03 2009-12-09 Dr. Reddy's Laboratories Ltd. Feste formen von pemetrexed
CA2718330A1 (en) * 2008-04-07 2009-10-15 Chelsea Therapeutics, Inc. Antifolate compositions
DK2384326T3 (da) 2008-08-20 2014-05-05 Zoetis Llc Pyrrolo[2,3-d]pyrimidinforbindelser
CN101684121B (zh) * 2008-09-22 2013-04-03 重庆医药工业研究院有限责任公司 培美曲塞二酸的新晶型及其制备方法
WO2011005832A1 (en) * 2009-07-08 2011-01-13 Chelsea Therapeutics, Inc. Stable crystalline polymorphs of the dipotassium salt of (s) -2- {4- [2- (2, 4-diamin0-quinaz0lin-6-yl) -ethyl] -benzoylamino} -4-methylenξ-penta nedioic acid
CA2779642A1 (en) * 2009-11-06 2011-05-12 Chelsea Therapeutics, Inc. Enzyme inhibiting compounds
WO2012064377A1 (en) * 2010-03-29 2012-05-18 Chelsea Therapeutics, Inc. Antifolate compositions
WO2012012404A1 (en) 2010-07-19 2012-01-26 Bayer Healthcare Llc Drug combinations with fluoro-substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
RU2552519C2 (ru) 2010-08-02 2015-06-10 Неон Лэборэторис Лтд. Способ получения высокочистого диалкилпеметрекседа
WO2012056285A1 (en) 2010-10-25 2012-05-03 Fresenius Kabi Oncology Ltd. An improved process for the preparation of pemetrexed
US8658652B2 (en) 2010-12-07 2014-02-25 Chelsea Therapeutics, Inc. Antifolate combinations
US9051322B2 (en) * 2011-03-23 2015-06-09 Scinopharm Taiwan, Ltd. Process for the production of a pemetrexed salt
CN103030640B (zh) * 2012-06-11 2015-04-22 江苏豪森医药集团连云港宏创医药有限公司 一种培美曲塞或其盐的制备方法
US10793573B2 (en) * 2017-08-31 2020-10-06 Duquesne University Of The Holy Spirit First-in-class of SHMT2 and MTHFD2 inhibitors as antitumor agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532241A (en) * 1982-08-26 1985-07-30 Sri International 8,10-Dideazaminopterins
US4684653A (en) * 1985-03-08 1987-08-04 The Trustees Of Princeton University Pyrido(2,3-d)pyrimidine derivatives
NO169490C (no) * 1988-03-24 1992-07-01 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater

Also Published As

Publication number Publication date
DK143789A (da) 1989-09-25
HU215928B (hu) 1999-03-29
US5106974A (en) 1992-04-21
EP0334636A2 (de) 1989-09-27
US5539113A (en) 1996-07-23
US5296600A (en) 1994-03-22
ES2092994T3 (es) 1996-12-16
NO891206D0 (no) 1989-03-20
HU203105B (en) 1991-05-28
CA1340794C (en) 1999-10-19
HUT51624A (en) 1990-05-28
KR960015967B1 (ko) 1996-11-25
CN1029970C (zh) 1995-10-11
DE68927354T2 (de) 1997-03-20
CN1037513A (zh) 1989-11-29
GR3021733T3 (en) 1997-02-28
EP0334636A3 (de) 1991-05-02
DK173980B1 (da) 2002-03-25
HU908458D0 (en) 1991-07-29
NO169490C (no) 1992-07-01
NO169490B (no) 1992-03-23
HUT55396A (en) 1991-05-28
DK143789D0 (da) 1989-03-22
US4997838A (en) 1991-03-05
NO891206L (no) 1989-09-25
EP0334636B1 (de) 1996-10-23
KR890014543A (ko) 1989-10-24
DE68927354D1 (de) 1996-11-28

Similar Documents

Publication Publication Date Title
ATE144513T1 (de) Pyrrolopyrimidinderivate, ihre herstellung und verwendung
ES2126068T3 (es) Derivados de estilbeno citotoxicos y composicion farmaceutica que los contiene.
ES2062143T3 (es) Derivados de pirrol sustituidos con grupos acriloilo y procedimiento para su preparacion.
SE8603099D0 (sv) Distamycin derivatives and process for their preparation
DE69216509D1 (de) Kondensierte Pyrimidinderivate, ihre Herstellung und ihre Verwendung als Antitumormittel
PT623133E (pt) Compostos de aminoalquilo substituidos
ATE35137T1 (de) Thieno(2,3-d)pyrimidin-derivate und deren salze.
IL89635A0 (en) Benzophenone derivatives,their preparation and their use as photoinitiators
ATE75226T1 (de) Substituierte triazinderivate.
DE69127691D1 (de) Be-13793c-derivat mit antitumorwirkung
DE69001111D1 (de) Antikrebs-zusammensetzung.
ES2056194T3 (es) Compuestos tetraciclicos antidepresivos.
ES2096572T3 (es) Nuevos derivados de glucosidos de antraciclina y procedimiento para su preparacion.
ATE141603T1 (de) Pyrrolopyrimidine, ihre herstellung und verwendung als tumorizide wirkstoffe
NZ221054A (en) Imidazo (2,1-a) isoquinoline derivatives and pharmaceutical compositions
DK0605078T3 (da) 5,6,7,9-tetrahydro-1,2,3-trimethoxy-9-oxobenzo alfa heptalenderivat
ES2081957T3 (es) Nuevos derivados sustituidos en posicion 15, de la 20,21-dinoreburnamenina, su procedimiento de preparacion y los nuevos productos intermedios asi obtenidos, su aplicacion como medicamentos y composiciones que los contienen.
DE3760054D1 (de) Substituted o-phthalaldehydes
ATE24887T1 (de) Cycloaliphatische alkohole.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time